On-Time Trials Require On-Time Startup, Even in a Pandemic
Sponsored by: PSI
- Study Startup
Date: 8 April
Time: 2PM London / 3PM CET
Understanding the Complexities, and the Keys to Success, in Study Startup During COVID-19
When it comes to delivering trials on time, every process matters. And, every timeline matters. In Study Startup, that means ensuring the right standards and processes are in place to launch a study. However, what happens when a global pandemic causes the start-up process, to slow down?
At PSI CRO, 75% of trials completed enrollment on time or ahead of schedule in 2020. In the middle of a global pandemic, our teams worked tirelessly to adapt, overcome, and deliver. In this webinar, dive in to one of the key parts of the clinical trial process that ensures trial timelines: Study Startup
Join Diana Fowler, Head of Study Startup, and Gopi Sadashivaiah, Director Study Startup, as they discuss the secrets of success to on-time study start up globally, even during a global pandemic.
Director of Study Startup
Gopi brings over 15 years of clinical research experience in monitoring, project management and study startup. Gopi is a medical graduate from Rajiv Gandhi University of Health Sciences, Bangalore, India. He began his clinical research career as a study coordinator and moved up to monitoring, Project Management and study startup. Gopi is passionate about study startup and his moto is “do everything that is possible to deliver the study drug to potential patients as quickly as possible”. In his current role, Gopi is responsible for overseeing study startup Department at PSI in North and Latin America.
Head of Study Startup
With nearly 20 years’ experience in the Clinical Research Industry, Diana Fowler, assumed the position of Head, Study Startup in 2019 at PSI. Her years in Project Management, provided a holistic view of managing global studies, while appreciating the difference in study outcome based on the success or failure of study startup. These lessons learned were her motivation to focus her attention to the process and procedures of study startup; reducing timelines and increasing transparency are the cornerstone to successful site activations.
Key Learning Objectives
- What is study startup, and how does it contribute to the overall clinical trial timeline?
- What are the key considerations sponsors should look for in a startup strategy?
- The secrets in the statistics: study startup during a pandemic (real-life examples and case studies of planned v. actual FPI)
- Clinical Operations
- Medical Director
- Heads of Clinical
- Heads of Outsourcing